Humacyte says interim Phase 3 data for ATEV in dialysis access to be presented Oct 22; sBLA filing expected this quarter

Humacyte says interim Phase 3 data for ATEV in dialysis access will be presented October 22, and expects to file an sBLA this quarter.

Detected & updated continuously · Source: Nebula

Story subjects

Track sentiment and mindshare across stocks and crypto in Nebula.

Open Nebula